Search

Your search keyword '"Bashash, Davood"' showing total 28 results
Start Over Author "Bashash, Davood" Publisher wiley
28 results on '"Bashash, Davood"'

14. Comparing the frequency of CD33 + pSTAT3 + myeloid‐derived suppressor cells and IL‐17 + lymphocytes in patients with prostate cancer and benign prostatic hyperplasia

Author

Sanaei, Mohammad‐Javad, primary, Taheri, Fatemeh, additional, Heshmati, Masoud, additional, Bashash, Davood, additional, Nazmabadi, Roya, additional, Mohammad‐Alibeigi, Faramarz, additional, Nahid‐Samiei, Mahboobeh, additional, Shirzad, Hedayatollah, additional, and Bagheri, Nader, additional

Published
2021
Full Text
View/download PDF

27. Monkeypox virus diagnosis and laboratory testing.

Author

Nakhaie M, Arefinia N, Charostad J, Bashash D, Haji Abdolvahab M, and Zarei M

Subjects
Humans, Monkeypox virus genetics, COVID-19 Testing, Mpox (monkeypox) diagnosis, Mpox (monkeypox) epidemiology, Mpox (monkeypox) pathology, COVID-19 diagnosis
Abstract

The multi-country outbreak of monkeypox virus (MPXV) infection, while the coronavirus disease 2019 pandemic is still an ongoing issue, has caused a new challenge. The re-emergence of MPXV and the rising incidence in non-endemic countries is turning into an upcoming threat to global health. Hence, rapid identification of the virus with appropriate methodology with the lowest false results plays a critical role in estimating the global extent of the crisis and providing preventive measures. This review summarised the main applicable strategies for primary detection and confirmation of MPXV and highlighted available data in biosafety, requirements, standard operating procedures, specimen collection, transportation and storage of clinical samples, and waste disposal of the viral agent. Also, various assays including molecular techniques, immunoassays, histopathological methods, electron microscopy, genomic sequencing, and cell culture have been illustrated. Moreover, we reflected on current knowledge of the advantages and disadvantages of each approach., (© 2022 John Wiley & Sons Ltd.)

Published
2023
Full Text
View/download PDF

28. Complement inhibition: A possible therapeutic approach in the fight against Covid-19.

Author

Deravi N, Ahsan E, Fathi M, Hosseini P, Yaghoobpoor S, Lotfi R, Pourbagheri-Sigaroodi A, and Bashash D

Subjects
Complement System Proteins, Humans, Inflammation, Pandemics, SARS-CoV-2, Respiratory Distress Syndrome, COVID-19 Drug Treatment
Abstract

The complement system, as a vital part of innate immunity, has an important role in the clearance of pathogens; however, unregulated activation of this system probably has a key role in the pathogenesis of acute lung injury, which is induced by highly pathogenic viruses (i.e. influenza A viruses and severe acute respiratory syndrome [SARS] coronavirus). The novel coronavirus SARS-CoV-2, which is the causal agent for the ongoing global pandemic of the coronavirus disease 2019 (Covid-19), has recently been spread to almost all countries around the world. Although most people are immunocompetent to SARS-CoV-2, a small group develops hyper-inflammation that leads to complications like acute respiratory distress syndrome, disseminated intravascular coagulation, and multi-organ failure. Emerging evidence demonstrates that the complement system exerts a crucial role in this inflammatory reaction. Additionally, patients with the severe form of Covid-19 show over-activation of the complement in their skin, sera, and lungs. This study aims to summarise current knowledge concerning the interaction of SARS-CoV-2 with the complement system and to critically appraise complement inhibition as a potential new approach for Covid-19 treatment., (© 2021 John Wiley & Sons Ltd.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results